Protara Therapeutics (TARA) Other Operating Expenses (2019 - 2022)
Protara Therapeutics (TARA) posted quarterly Other Operating Expenses of $29.5 million for Q4 2022, up 44.66% year-over-year from $20.4 million in Q4 2021, and up 44.66% quarter-over-quarter from $20.4 million in Q4 2021.
Protara Therapeutics (TARA) Other Operating Expenses (2019 - 2022) Analysis & Trends
Protara Therapeutics (TARA) has reported Other Operating Expenses for 4 consecutive years, with $29.5 million the latest figure, recorded in Q4 2022.
- In Q4 2022, Other Operating Expenses rose 44.66% year-over-year to $29.5 million; the TTM figure through Sep 2023 stood at $29.5 million (up 44.66% YoY), while the FY2022 annual figure was $29.5 million, up 44.66% from the prior year.
- Other Operating Expenses improved to $29.5 million in Q4 2022 per TARA's latest filing, from $20.4 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $29.5 million in Q4 2022 and bottomed at -$2.9 million in Q4 2019.
- Historically, Other Operating Expenses has averaged $14.7 million across 4 years, with a median of $16.1 million in 2020.
- Annual changes were most pronounced in 2020 — Other Operating Expenses jumped 505.97% — and 2022, when it surged 44.66%.
- Protara Therapeutics' Other Operating Expenses stood at -$2.9 million in 2019, then surged by 505.97% to $11.8 million in 2020, then surged by 73.31% to $20.4 million in 2021, then jumped by 44.66% to $29.5 million in 2022.
- Business Quant data shows TARA's Other Operating Expenses at $29.5 million in Q4 2022, $20.4 million in Q4 2021, and $11.8 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Protara Therapeutics | 234.56 Mn | 234.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 29.52 Mn |
| Dec 31, 2021 | 20.40 Mn |
| Dec 31, 2020 | 11.77 Mn |
| Dec 31, 2019 | -2.90 Mn |